The average price reduction of 327 selected products saved 18.5 billion yuan per year -focusing on the seventh batch of national organization drug collection

Xinhua News Agency, Nanjing, July 12th. Question: The average price reduction of 327 products to be selected by 48% is 18.5 billion yuan per year

Xinhua News Agency reporters Peng Yunjia and Qiu Bingqing

The seventh batch of national organizational medicines ended on the 12th in Nanjing, Jiangsu, and produced the results of the selection: purchase incorporated into 60 medicines, 327 selected products to reduce the price by 48%. 100 million yuan.

This is the first national collection of drug collection in 2022. It involves many categories of drugs, the proportion of optimized drugs, and the use of "one province and double confession".

The coverage of 31 categories of drugs is further expanded

This time the national organizational drug collection involves 31 treatment categories, including common diseases such as hypertension, diabetes, anti -infection, digestive tract diseases, and major diseases such as lung cancer, liver cancer, kidney cancer, and bowel cancer. wide.

"It is worth mentioning that this collection has incorporated more new drugs, which greatly improves the accessibility of medication." Lu Yun, a professor at the International Medical Business School of China University of Pharmacy, said that there are fewer types of treatment drugs for liver cancer. Many of them are new drugs, which are high in price, but the just -who has just passed the patent period is included in the collection, which can benefit more patients.

As a targeted medicine for liver cancer, Lelini Capsules decreased from 108 yuan to an average of 18 yuan per capsule. A treatment cycle can save 8,100 yuan.

In addition, for the first time in the field of lowering blood pressure, the slow -controlled release type, the price of nifeding the horizontal control sheet is 58%, and the price of Matolol's sustained -release tablet is 53%. The film decreases from the average of 4.5 yuan to 1 yuan.

Lu Yun said that there are still anti -discharge drugs in the medicines incorporated into the collection of collection this time. Pick".

Optimize the proportion of medicines for the proportion of people.

In the previous national organizational drug collection, antibiotics did not distinguish between levels and reduced the agreed purchase volume by uniformly reduced the agreed purchase volume.

"Among the seventh batch of national organizational drug collection, the agreed purchase volume of 4 antibiotics decreased by 10%on the basis of other antibiotics, which is 20%lower than ordinary varieties." Lu Yun said that special -level antibiotic drugs have further reduced The proportion of bands will play a guidance and standardized role in the reasonable medication of grass -roots medical institutions.

Chang Feng, Dean of the International School of Pharmaceutical Business, China Pharmaceutical University, said that from the perspective of optimization and decreased proportion of the variety of drug collection in the seventh batch Essence This will make the results of the collection of collection more operable and more fit the actual market usage of the variety.

According to the relevant person in charge of the National Medical Insurance Bureau, the products of 217 companies in this collection have been qualified for the selection. The proportion of bidding enterprises is 73%, and the average variety of drugs has 5.4 enterprises. The supply of diversification and stability has been further enhanced.

As of now, the national organizational drug collection has covered 294 kinds of medicines, and calculated according to the pre -mining price, involving a amount of about 35%of the procurement of chemical drugs and biopharmaceuticals in public medical institutions.

"One province and double confession" effective guarantee clinical medication

In order to better guarantee the stable supply of collection drugs, this time the national drug collection is introduced for the first time "a provincial double supply and dual guarantee" method.

Chang Feng explained that according to the results of the selection of medicines, the selected varieties of the selected enterprises cannot be supplied or canceled in time in a timely manner, so that when the agreement cannot continue to be fulfilled, the province's alternative enterprise will supply the corresponding selection varieties. This will provide dual guarantees for the timely, stable and smooth supply of medicines.

"This rule also reflects the equivalent of rights and obligations to a certain extent. Alternative companies need to select prices in the preparation area to have the opportunity to obtain more market demand in the province." As far as the medical insurance department is concerned, the "one province and double confession" provides more insurance and direct means to meet the demand for market supply, which further reduces the administrative cost of choosing a substitute enterprise in each province.

"Ji Cai will achieve a win -win situation for patients, hospitals, and enterprises." Jiang Changsong, director of the Price Recruitment Office of the National Medical Security Research Institute of the Capital Medical University, said that entering the new era of medical prices and medical insurance negotiations has become the formation of medical prices. Two mechanisms, jointly promoting medical prices reasonable.

According to reports, the results of the official selection will be released after the results of the selection results, and it is expected to be implemented in November 2022.

[Editor in charge: Feng Li]

- END -